Skip to content

A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation

A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02894970
Enrollment
120
Registered
2016-09-09
Start date
2016-10-31
Completion date
2017-07-31
Last updated
2016-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patent Ductus Arteriosus, Pulmonary Hypertension

Brief summary

To evaluate feasibility of photoplethysmography (PPG) of pulmonary arteries in adults children and neonates and to compare normal controls to premature newborns suffering from patent ductus arteriosus and neonates suffering from pulmonary hypertension.

Detailed description

This study aims to check a new device for measuring lung photoplethysmography (PPG) of pulmonary arteries by delivering light through the chest wall. The aim is to evaluate pulmonary arteries' elasticity and oxygen saturation. We will study adults children and neonates. We will study 20 healthy adults, 20 healthy children aged 2-8 years, twenty healthy neonates, 20 preterm neonates with patent ductus arteriosus (PDA) and 20 preterm neonates with no PDA. We will study also 20 neonates with pulmonary hypertension. Each participant will be examined for 5 minutes and PPG signal will be recorded in a computer and evaluated offline later on. Pulmonic saturation will be calculated from absorption difference between two wave lengths of infrared light that will be used. Our hypothesis is that the mentioned clinical conditions will affect PPG signal and pulmonary arterial oxygen saturation.

Interventions

DEVICEPulmonary PPG

Five minutes check with a lights source with two wave lengths of infrared and a detector.

Sponsors

Israel Science Foundation
CollaboratorOTHER
Shaare Zedek Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Hemodynamic stability

Exclusion criteria

* hemodynamic instability

Design outcomes

Primary

MeasureTime frame
difference in PPG or pulmonary saturation between conditions1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026